You have 9 free searches left this month | for more free features.

lung injury

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

NSCLC Trial in Worldwide (pembrolizumab, pemetrexed, carboplatin)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • pembrolizumab
  • +4 more
  • Los Angeles, California
  • +157 more
Aug 18, 2022

Cognitive Function and Health-related Quality of Life After

Not yet recruiting
  • Acute Brain Injury
  • +5 more
  • no intervention
  • (no location specified)
May 5, 2021

Lung Cancer Trial in Houston (Ibrutinib)

Completed
  • Lung Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 21, 2021

Right Heart Dysfunction and Preload Responsiveness in Open Heart

Completed
  • Cardiac Surgery
  • passive leg raising maneuver (PLR)
  • +2 more
  • Saint-Étienne, France
    CHU de Saint-Etienne
Feb 3, 2021

Nocturia Trial in Newport Beach (SER120)

Completed
  • Nocturia
  • Newport Beach, California
    Stephen M. Auerbach, MD
Dec 23, 2020

Coronary Artery Disease Trial in Baltimore (Methotrexate, Colchicine, Placebo)

Completed
  • Coronary Artery Disease
  • Baltimore, Maryland
    Johns Hopkins Hospital
Sep 24, 2021

ctDNA in Cancer Early Detection and STAS Evaluation in GGOs

Not yet recruiting
  • Lung Cancer
  • +2 more
  • cf DNA and ct DNA
  • Roma, Italy
    Thoracic Surgery Unit, Sapienza University of Rome
Mar 31, 2022

Postoperative Respiratory Complications Trial in Umeå (Positive airway pressure (PEP), Speaking loudly during about 3 minutes,

Completed
  • Postoperative Respiratory Complications
  • Positive airway pressure (PEP)
  • +2 more
  • Umeå, Umea, Sweden
    Dept of Surgery, Inst of Surgical and Perioperative sciences
Mar 19, 2022

Breast Cancer Trial in Philadelphia (Reader Study - Imagio Ultrasound, Reader Study Imagio Ultrasound + Optoacoustic Imaging,

Completed
  • Breast Cancer
  • Reader Study - Imagio Ultrasound
  • +2 more
  • Philadelphia, Pennsylvania
    American College of Radiology Center for Research and Innovation
Jul 9, 2021

Advanced Solid Tumors, Metastatic Solid Tumors Trial in New York (Mogamulizumab (KW-0761))

Completed
  • Advanced Solid Tumors
  • Metastatic Solid Tumors
  • Mogamulizumab (KW-0761)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 30, 2021

Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors Trial in Beverly Hills, Houston (NOX66, EBRT)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors
  • Beverly Hills, California
  • +1 more
Nov 14, 2021

Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT

Recruiting
  • Lung Cancer Stage III
  • Lung Cancer Stage IV
    • Brest, France
      Chu Brest
    Aug 16, 2023

    NSCLC Stage II, NSCLC Stage III, PET/CT Trial in ZhuHai (pembrolizumab, pemetrexed, gemcitabine, cisplatin, carboplatin)

    Unknown status
    • Non-small Cell Lung Cancer Stage II
    • +2 more
    • pembrolizumab, pemetrexed, gemcitabine, cisplatin, carboplatin
    • ZhuHai, Guangdong, China
      the fifth affiliated hospital of Sun yat-sen university
    Aug 22, 2021

    Septic Shock Trial in Milwaukee (Hydroxocobalamin, Placebo)

    Recruiting
    • Septic Shock
    • Milwaukee, Wisconsin
      Medical College of Wisconsin
    Nov 30, 2021

    Diffuse Cutaneous Systemic Sclerosis, Interstitial Lung Disease Trial in Worldwide (PRA023 IV, Companion diagnostic ( CDx),

    Recruiting
    • Diffuse Cutaneous Systemic Sclerosis
    • Interstitial Lung Disease
    • PRA023 IV
    • +2 more
    • Los Angeles, California
    • +13 more
    Jul 12, 2022

    NO/CO Diffusing Capacity in Thoracic Radiation Therapy

    Terminated
    • Radiotherapy
      • Zürich, Switzerland
        University Hospital of Zurich
      Apr 16, 2021

      Vehicular Environment Trial in New York (device, behavioral, other)

      Completed
      • Vehicular Environment
      • HEPA air purifier
      • +3 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Sep 8, 2021

      Thrombotic Thrombocytopenic Purpura Trial (Aspirin tablet, Placebo)

      Not yet recruiting
      • Thrombotic Thrombocytopenic Purpura
      • Aspirin tablet
      • Placebo
      • (no location specified)
      Sep 30, 2022

      Hip Fractures Trial in Worldwide (VK5211, Placebo)

      Completed
      • Hip Fractures
      • Yorba Linda, California
      • +20 more
      Apr 22, 2021

      Tumors, NSCLC Trial (Epacadostat 25 mg, Epacadostat 100 mg, pembrolizumab 200 mg)

      Completed
      • Neoplasms
      • Carcinoma, Non-Small-Cell Lung
      • Epacadostat 25 mg
      • +7 more
      • (no location specified)
      Aug 17, 2022

      Evaluate CBCT Protocols in Subjective Image Quality Trial in Stockholm (Ultra-low dose protocol, Standard dose protocol)

      Completed
      • Evaluate CBCT Protocols in Subjective Image Quality
      • Ultra-low dose protocol
      • Standard dose protocol
      • Stockholm, Sweden
        Karolinska Institutet
      Apr 28, 2022

      Asthma Trial in Worldwide (QVM149 150/50/80 µg o.d., QVM149 150/50/160 µg o.d., salmeterol/fluticasone FDC 50/500 µg b.i.d.)

      Completed
      • Asthma
      • QVM149 150/50/80 μg o.d.
      • +2 more
      • Sofia, Bulgaria
      • +11 more
      Sep 30, 2021

      Asthma Trial in Shanghai (ACT guided Routine Treatment, Routine Treatment)

      Completed
      • Asthma
      • ACT guided Routine Treatment
      • Routine Treatment
      • Shanghai, China
      • +5 more
      Jun 15, 2021

      Asthma Trial in Bronx, New York (Environmental Intervention)

      Completed
      • Asthma
      • Environmental Intervention
      • Bronx, New York
      • +1 more
      Jan 21, 2022

      Traumatic Brain Injury Trial in Sheffield (Swisse Womens 50+ Ultivite Multivitamin, Holland and Barrett Triple Strength Omega-3

      Completed
      • Traumatic Brain Injury
      • Swisse Womens 50+ Ultivite Multivitamin
      • Holland and Barrett Triple Strength Omega-3 Fish Oil
      • Sheffield, South Yorkshire, United Kingdom
        Sheffield Hallam University
      Oct 20, 2020